TAM
BIIB icon

Trillium Asset Management’s Biogen BIIB Stock Holding History

Trillium Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-849
Closed -$252K – 235
2019
Q4 		$252K Sell
849
-592
-41% -$164K 0.01% 243
2019
Q3 		$336K Buy
1,441
+358
+33% +$83.4K 0.02% 226
2019
Q2 		$253K Sell
1,083
-20,831
-95% -$4.81M 0.01% 217
2019
Q1 		$5.18M Sell
21,914
-11,782
-35% -$3.71M 0.26% 113
2018
Q4 		$10.1M Sell
33,696
-1,482
-4% -$473K 0.59% 65
2018
Q3 		$12.4M Buy
35,178
+323
+0.9% +$111K 0.62% 61
2018
Q2 		$10.1M Sell
34,855
-209
-0.6% -$58.8K 0.54% 73
2018
Q1 		$9.6M Buy
35,064
+498
+1% +$155K 0.53% 72
2017
Q4 		$11M Sell
34,566
-499
-1% -$160K 0.61% 69
2017
Q3 		$11M Sell
35,065
-3,170
-8% -$939K 0.63% 64
2017
Q2 		$10.4M Buy
38,235
+266
+0.7% +$70.3K 0.62% 65
2017
Q1 		$10.4M Sell
37,969
-797
-2% -$225K 0.66% 60
2016
Q4 		$11M Sell
38,766
-1,998
-5% -$592K 0.72% 57
2016
Q3 		$12.8M Sell
40,764
-1,936
-5% -$573K 0.82% 47
2016
Q2 		$10.3M Sell
42,700
-3,087
-7% -$814K 0.68% 62
2016
Q1 		$11.9M Buy
45,787
+126
+0.3% +$33.3K 0.79% 46
2015
Q4 		$14M Sell
45,661
-877
-2% -$252K 0.95% 32
2015
Q3 		$13.6M Buy
46,538
+10,887
+31% +$3.6M 0.95% 35
2015
Q2 		$14.4M Buy
35,651
+11,920
+50% +$4.78M 0.92% 37
2015
Q1 		$10M Buy
23,731
+5,431
+30% +$2.14M 0.65% 58
2014
Q4 		$6.21M Buy
+18,300
New +$5.92M 0.42% 98

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Trillium Asset Management's BIIB Position: Q1 2020 in Review

Trillium Asset Management sold out of Biogen (BIIB) in Q1 2020, closing a stake of 849 shares — an estimated $252K sold.

Trillium Asset Management first reported a position in BIIB in Q4 2014 and held it in 21 quarters. The position peaked at $14.4M in Q2 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Trillium Asset Management reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Trillium Asset Management sold 849 Biogen shares in Q1 2020, an estimated $252K.
  • Trillium Asset Management first reported a position in Biogen in Q4 2014 and held it in 21 quarters.
  • Trillium Asset Management's Biogen position peaked at $14.4M in Q2 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Trillium Asset Management's 13F filing for Q1 2020, filed 7 May 2020.